Impact of renal failure on the risk of myocardial infarction and death

Kidney International

Volumn 62, Issue 5, 2002, Pages 1776-1783

  Beddhu, Srinivasan ^a,b,c   Allen Brady, Kristina ^a,b,c   Cheung, Alfred K ^a,b,c   Horne, Benjamin D ^a,b,c   Bair, Tami ^a,b,c   Muhlestein, Joseph B ^a,b,c   Anderson, Jeffrey L ^a,b,c  

^a VA Salt Lake City Healthcare System   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; Death; Myocardial infarction; Uremia

Indexed keywords

CARDIOVASCULAR AGENT;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CALCULATION; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING;

EID: 0036408408     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00629.x     Document Type: Article

References (34)

1. U.S RENAL DATA SYSTEM: Death rates by primary cause of death, in 2000 Annual Data Report, Reference Tables, Table H 18, Bethesda, NIH, NIDDK, 2000, p 659
2. Sarnak MJ, Levey AS: Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis 35(Suppl):Sl17-131, 2000
3. US RENAL DATA SYSTEM: Medication use among dialysis patients in the dialysis morbidity and mortality study. USRDS 1998 Annual Data Report, (chapt IV), Bethesda, NIH, NIDDK, 1998, pp 51-62
4. Cheung A, Sarnak M, Yan G, et al: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58:353-362, 2000
5. Anderson JL, King GJ, Thomson MJ, et al: A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction. J Am Coll Cardiol 30:1206-1211, 1997
6. Anderson JL, Carlquist JF, Muhlestein JB, et al: Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 32:35-41, 1998
7. Anderson JL, Muhlestein JB, Carlquist J, et al: Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. Circulation 99:1540-1547, 1999
8. Anderson JL, Muhlestein JB, Horne BD, et al: Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation 102:1227-1232, 2000
9. Anderson JL, Habashi J, Carlquist JF, et al: A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease. J Am Coll Cardio136:1248-1252, 2000
10. Muhlestein JB, Hammond EH, Carlquist JF, et al: Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 27:1555-1561, 1996
11. Muhlestein JB, Horne BD, Carlquist JF, et al: Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 102:1917-1923, 2000
12. Muhlestein JB, Anderson JL, Carlquist JF, et al: Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: Primary clinical results of the ACADEMIC study. Circulation 102:1755-1760, 2000
13. Muhlestein JB, Anderson JL, Hammond EH, et al: Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 97:633-636, 1998
14. Mclellan T, Jorde LB, Skolnick MH: Genetic distances between the Utah Mormons and related populations. Am J Hum Genet 36:836-857, 1984
15. Myocardial infarction and mortality in the Coronary Artery Surgery Study (CASS) randomized trial. N Engl J Med 310:750-758, 1984
16. Levey AS, Bosch JP, Lewis JB, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470, 1999
17. U.S RENAL DATA SYSTEM: Five year and ten-year survival probabilities, in 2000 Annual Data Report. Reference Tables, Table 1.24 and 1.25, Bethesda, NIH, NIDDK, 2000
18. Fried LP, Kronmal RA, Newman AB, et al: Risk factors for 5-year mortality in older adults: The Cardiovascular Health Study. JAMA 279:585-592, 1998
19. Yusuf SSP, Pogue J, Bosch J, et al: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:145-153, 2000
20. US RENAL DATA SYSTEM: Incidence and prevalence of ESRD (chapt 1), in 2000 Annual Data Report, Bethesda, NIH, NIDDK, 2000
21. Stenvlnkel P, Heimburger O, Paultre F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
22. Tonelli M, Bohm C, Pandeya S, et al: Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis 37:484-489, 2001
23. Jungers P, Massy ZA, Khoa TN, et al: Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: A prospective study. Nephrol Dial Transplant 12:2597-2602, 1997
24. Shulman NB, Ford CE, Hall WD, et al: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13:180-193, 1989
25. Goodman WG, Goldin J, Kuizon BD, et al: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483, 2000
26. Block GA, Port FK: Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am J Kidney Dis 35:1226-1237, 2000
27. Bostom AG, Shemin D, Gohh RY, et al: Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients. Kidney Int 59(Suppl 78):S246-252, 2001
28. Bostom AG, Lathrop L: Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 52:10-20, 1997
29. Stenvinkel P, Lindholm B, Heimburger M, Heimburger O: Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: Association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant 15:1624-1630, 2000
30. Ridker PM, Hennekens CH, Burinc JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843, 2000
31. Ridker PM, Rifai N, Pfeffer M, et al: Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101:2149-2153, 2000
32. Zimmermann J, Herrlinger S, Pruy A, et al: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658, 1999
33. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35:469-476, 2000
34. Shlipak MG, Noguchi H, McClellan M, et al: Effects of renal insufficiency on treatment and survival after myocardial infarction in the elderly, http://www.va.gov/resdev/programs/hsrd/hsrd_ab_01/HSRD2001AMab113.htm